Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Approval Study 2: Hintermann Series H3 Total Ankle Replacement System

NCT04770870 is registered in ClinicalTrials.gov with DT MedTech, LLC as lead sponsor.

NCT NCT04770870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04770870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Approval Study 2: Hintermann Series H3 Total Ankle Replacement System
Lead sponsor
DT MedTech, LLC
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 1, 2022
Completion date
December 31, 2029
Enrollment
94 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis ankle, osteoarthritis of ankle secondary to inflammatory arthritis (disorder), post-traumatic osteoarthritis of ankle